ZEOMBUS Trademark

Trademark Overview

On Wednesday, April 27, 2011, a trademark application was filed for ZEOMBUS with the United States Patent and Trademark Office. The USPTO has given the ZEOMBUS trademark a serial number of 79098729. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, April 27, 2021. This trademark is owned by NOVARTIS AG. The ZEOMBUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based disorders and diseases, autoimmune disorders and diseases, renal diseases and disorders, diabetes; antibiotic, antiviral, anti-infection and anti-mycotic preparations
zeombus

General Information

Serial Number79098729
Word MarkZEOMBUS
Filing DateWednesday, April 27, 2011
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, April 27, 2021
Registration Number4085965
Registration DateTuesday, January 17, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based disorders and diseases, autoimmune disorders and diseases, renal diseases and disorders, diabetes; antibiotic, antiviral, anti-infection and anti-mycotic preparations
Translation of Words in MarkThe wording "ZEOMBUS" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, May 8, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events

Event DateEvent Description
Monday, December 6, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, December 6, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, January 26, 2018NOTIFICATION PROCESSED BY IB
Friday, May 26, 2017NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, May 26, 2017DEATH OF INTERNATIONAL REGISTRATION
Tuesday, January 17, 2017COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, April 13, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, August 10, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, July 25, 2012FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, July 25, 2012FINAL DISPOSITION PROCESSED
Tuesday, April 17, 2012FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 17, 2012REGISTERED-PRINCIPAL REGISTER
Saturday, December 31, 2011NOTIFICATION PROCESSED BY IB
Tuesday, November 1, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 1, 2011PUBLISHED FOR OPPOSITION
Wednesday, October 12, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 12, 2011NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Monday, September 26, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 26, 2011ASSIGNED TO LIE
Wednesday, September 14, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 14, 2011EXAMINER'S AMENDMENT ENTERED
Wednesday, September 14, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 14, 2011EXAMINERS AMENDMENT E-MAILED
Wednesday, September 14, 2011EXAMINERS AMENDMENT -WRITTEN
Monday, September 12, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 12, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, August 13, 2011REFUSAL PROCESSED BY IB
Thursday, July 28, 2011NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, July 28, 2011REFUSAL PROCESSED BY MPU
Thursday, July 28, 2011NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 27, 2011NON-FINAL ACTION WRITTEN
Monday, July 25, 2011ASSIGNED TO EXAMINER
Saturday, July 16, 2011APPLICATION FILING RECEIPT MAILED
Tuesday, July 12, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 11, 2011LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, July 8, 2011SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

zeombus disorders system diseases preparations treatment pharmaceutical prevention anti bacteria gastroenterological